Review of Optometry
In May, the FDA approved a new vaccine, Zostavax (live attenuated zoster vaccine, Merck) to prevent herpes zoster (shingles). The vaccine is approved for adults ages 60 and older who have had chickenpox but have not yet had shingles.
Friday, November 17, 2006
VACCINE FOR SHINGLES
Review of Optometry
In May, the FDA approved a new vaccine, Zostavax (live attenuated zoster vaccine, Merck) to prevent herpes zoster (shingles). The vaccine is approved for adults ages 60 and older who have had chickenpox but have not yet had shingles.
In May, the FDA approved a new vaccine, Zostavax (live attenuated zoster vaccine, Merck) to prevent herpes zoster (shingles). The vaccine is approved for adults ages 60 and older who have had chickenpox but have not yet had shingles.
Subscribe to:
Posts (Atom)